̽»¨Ö±²¥

Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman’s cancer is responding to treatment, according to a new study published in the New England Journal of Medicine.

Scientists have carried out the first ever genome scan for womb cancer and discovered a genetic region that reduces risk of the disease, according to a Cambridge study published in Nature Genetics on Sunday, 17 April.